Brad Groves is Director of NICE Advice at the National Institute for Health and Care Excellence (NICE). He leads advisory services focused on market access, health technology assessment, and evidence strategy, helping life sciences and health technology organisations bring innovative products to patients more effectively. With extensive experience working across the life sciences, health technology, and healthcare sectors, Brad supports developers, investors, and health system leaders to accelerate patient access to innovative technologies. He has particular expertise in strategic market access, payer engagement, and fostering collaboration between industry, healthcare systems, and policy makers. Through his work at NICE, he has helped organisations across the UK and internationally understand and respond to evolving evidence, reimbursement, and adoption requirements for innovative healthcare solutions.